Giles Mark T. - 01 Jul 2021 Form 4 Insider Report for Diffusion Pharmaceuticals Inc. (CRVO)

Role
Director
Signature
/s/ William R. Elder, as attorney-in-fact for the Reporting Person
Issuer symbol
CRVO
Transactions as of
01 Jul 2021
Net transactions value
$0
Form type
4
Filing time
06 Jul 2021, 21:41:18 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DFFN Stock Option (Right to Buy) Award $0 +83,300 $0.000000 83,300 01 Jul 2021 Common Stock 83,300 $0.7200 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the options will vest in 12 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a 12-month period beginning July 1, 2021.